von Willebrand Disease in Dental Clinic: An Exclusive Case Report with Review of Literature
M Aparna
Citation Information :
Aparna M. von Willebrand Disease in Dental Clinic: An Exclusive Case Report with Review of Literature. J Contemp Dent 2015; 5 (2):107-112.
von Willebrand factor to the rescue. Blood 2009;113:5049-5057.
Sequence and structure relationships within von Willebrand factor. Blood 2012;120: 449-458.
Genetic induction of a releasable pool of factor VIII in human endothelial cells. Arterioscler Thromb Vasc Biol 2000;20: 2689-2695.
Interactions between von Willebrand factor and factor VIII: where did they first meet? J Pediatr Hematol Oncol 2000;22:269-275.
von Willebrand disease, hemophilia A and B, and other factor deficiencies. Int Anesthesiol Clin 2004;42:59-76.
von Willebrand disease and cardiopulmonary bypass: a case report. AANA J 2013;81:60-64.
von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy. Blood 2013;122: 3735-3740.
von Willebrand disease (VWD): evidencebased diagnosis and management guidelines, the National heart, lung, and blood institute (NHLBI) expert panel report (USA). Haemophilia 2008;14:171-232.
Acquired von Willebrand syndrome: data from an international registry. Thromb Haemost 2000;84:345-349.
Acquired von Willebrand syndrome: from pathophysiology to management. Thromb Haemost 2000;84:175-182.
Type 1 von Willebrand disease: a clinical retrospective study of the diagnosis, the influence of the ABO blood group and the role of the bleeding history. Br J Haematol 2000;108: 259-264.
Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP. J Clin Invest 2000;106:107-116.
Desmopressin: a nontransfusional treatment of hemophilia and von Willebrand disease. Haemostasis 1992;22:276-280.
Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease. Br J Haematol 1981;47:283-293.
Intranasal and intravenous administration of desmopressin: effect on F VIII/vWF, pharmacokinetics and reproducibility. Thromb Haemost 1987;58:1033-1036.
Intravenous and subcutaneous administration of desmopressin (DDAVP) to hemophiliacs: pharmacokinetics and factor VIII responses. Thromb Haemost 1987;58:1037-1039.
Pharmacokinetics, efficacy and safety of Humate-P in von Willebrand disease. Haemophilia 1998;4(Suppl 3):33-39.
Clinical guidelines for treating von Willebrand disease patients who are not candidates for DDAVP-a survey of European physicians. Haemophilia 1998;4(Suppl 3):11-14.
Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study. Blood 2002;99:450-456.
The prevention of secondary haemorrhage after prostatectomy: the value of antifibrinolytic therapy. Br J Urol 1980;52:26-28.
Optimising local therapy during oral surgery in patients with von Willebrand disease: effective results from a retrospective analysis of 63 cases. Haemophilia 2000; 6:71-77.
Dental extractions in patients with bleeding disorders: the use of fibrin glue. Oral Surg Oral Med Oral Pathol 1993;75:280-282.
Comparison of two topical collagen-based hemostatic sponges during cardiothoracic procedures. J Invest Surg 1999; 12:101-106.
Clinical applications and biosafety of human adult mesenchymal stem cells. Curr Pharm Des 2012;18:1821-1845.
MASAC recommendation 128: MASAC recommendations for hepatitis A and B immunization of individuals with bleeding disorders (Monograph on the Internet). New York: National Hemophilia Foundation, c2006. Available at: http://www.hemophilia.org/research/masac/masac128.htm, accessed on Nov. 2001.
The postaspirin bleeding time: a screening test for evaluating haemostatic disorders. Br J Haematol 1979;43:649-659.
Oral contraceptives and DDAVP nasal spray: patterns of use in managing vWD-associated menorrhagia: a single-institution study. J Pediatr Hematol Oncol 2005;27: 357-363.
Factor VIII: C increases after desmopressin in a subgroup of patients with autosomal recessive severe von Willebrand disease. Br J Haematol 1995;89:147-151.
Haemostasis in oral surgery—the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system. Dan Med Bull 1991;38:427-443.
